logo
  

Core Laboratories NV (CLB) Fell To A New Low After Weak Q4 Report

Core Laboratories NV (CLB) reported fourth quarter EPS of $1.51 after the bell Wednesday, compared to $1.42 in the prior year period. Analysts expected EPS of $1.54.

Core Laboratories gapped down sharply Wednesday, but moved in a narrow range throughout the session. The stock closed lower by 10.74 at $89.10, with volume at over an 8-month high. Core Laboratories dropped below a 2-week trading range and set a new low for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT